Immunity against hepatitis B and measles vaccination after chemotherapy for acute lymphoblastic leukaemia in children: revaccination policy
Main Author: | Francesca Fioredda |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2012-01-01
|
Series: | Revista Brasileira de Hematologia e Hemoterapia |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842012000400005 |
Similar Items
-
Antibody responses to Hepatitis B and measles-mumps-rubella vaccines in children who received chemotherapy for acute lymphoblastic leukemia
by: Simone Santana Viana, et al.
Published: (2012-01-01) -
Prevalence of hepatic dysfunction during induction chemotherapy for acute lymphoblastic leukaemia and lymphoblastic lymphoma in children and its effects on subsequent therapy
by: Nalla Anuraag Reddy, et al.
Published: (2022-01-01) -
Seroepidemiological Study of Measles Virus among Young Adults: Response to Revaccination
by: Baghdad Science Journal
Published: (2014-12-01) -
Revaccination against hepatitis B in late teenagers who received vaccination during infancy: Yes or no?
by: Hong Zhao, et al.
Published: (2018-02-01) -
Measles seroepidemiology among adolescents and young adults: Response to revaccination, Sari, 2003
by: MJ Saffar, et al.
Published: (2006-01-01)